Anzeige
Mehr »
Mittwoch, 09.09.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
539 Leser
Artikel bewerten:
(2)

Sonicu Introduces New Monitoring Package Tailored for Life Science and Laboratories

Enhanced FDA reporting, full IQ/OQ package & incubator monitoring sensor round out Lab21 offerings

GREENFIELD, IN / ACCESSWIRE / May 16, 2023 / A national leader in temperature and environmental monitoring serving the research and laboratory industries is introducing an enhanced suite focused on better serving the life science professional focused on compliance automation and asset protection.

Environmental Monitoring for Laboratories

Environmental Monitoring for Laboratories
Sonicu, which serves scores of public and private laboratories and research-intensive universities across North America, is improving its ability to serve their exacting Food and Drug Administration regulatory needs with its Lab21 offering.

Sonicu, which serves scores of public and private laboratories and research-intensive universities across North America, is improving its ability to serve their exacting Food and Drug Administration regulatory needs with its Lab21 offering.

Lab21 represents a significant upgrade in delivering affordable and simple monitoring and compliance services, including:

  • Enhanced software features to comply with FDA 21 CFR Part 11 requirements
  • Group reports and the ability to have users all be able to comment/review/approve reports with cover sheets
  • Strict personnel controls and enhanced audit trails required by the FDA
  • Rapid alarm and notification testing with SoniCloud Validation Alarm feature for PQ compliance
  • A password allowing users to time-stamp who and when specific actions are executed
  • Double-verification, compliant with 21 CFR Part 11, for significant changes to the system settings
  • Full probe calibration history and regularly updated monitoring system health reports
  • Access restriction to unauthorized users, device check performance and support written procedures and system documentation which are all required for full compliance
  • White glove IQ/OQ offering to help customers streamline implementation

Joe Mundell, Chief Revenue Officer, Sonicu, said the new offering reflects significant growth in the life science industry around protecting their research and complying with increasingly strict regulatory requirements.

"Lab21 represents feedback from dozens of customers who request more sophisticated monitoring and regulatory reporting to support their research," Mundell said.

"We've worked closely with our customers to develop the features and functionality they need to work more efficiently and stay compliant."

When coupled with the Sonicu Incubator Monitoring sensor, which includes temperature, humidity and CO2, the new package is ideal for laboratory or life science applications.

The incubator monitor installs in minutes and configures simply into the SoniCloud software, providing real-time and historical visibility to help researchers validate their work and remain compliant with Food and Drug Administration guidelines.

When combined with our robust suite of temperature monitoring solutions, Sonicu offers labs and life science organizations the opportunity to consolidate their monitoring, protect their perishable assets and automate tedious regulatory reporting.

All Sonicu monitoring systems can be supported with our SNAP calibration program which automates the NIST calibration process, delivering another layer of compliance simplicity.

When coupled with the robust IQ/OQ service, Sonicu has the ability to help more labs with superior compliance readiness.

IQ and OQ protocols are methods for showing that the equipment being used or installed will deliver a high degree of assurance so production processes will consistently manufacture products that meet quality requirements.

Scores of laboratories and similar organizations, including the Ohio University Innovation Center, Xytex Sperm Bank and MiraVista Diagnostics, rely on Sonicu for their temperature and environmental monitoring.

Contact Information

Bryan Mitchell
Vice President
bmitchell@sonicu.com
202-718-5155

SOURCE: Sonicu

.

View source version on accesswire.com:
https://www.accesswire.com/755089/Sonicu-Introduces-New-Monitoring-Package-Tailored-for-Life-Science-and-Laboratories

© 2023 ACCESS Newswire
KI braucht Strom
Halbleiter, Speicherchips und Rechenzentren haben Anlegern im KI-Boom bereits enorme Gewinne beschert. Doch jetzt zeichnet sich mit der benötigten Energie der nächste große Flaschenhals ab. Neue KI-Rechenzentren benötigen nicht mehr einige Megawatt, sondern zum Teil mehrere Gigawatt Leistung – so viel wie mehrere moderne Kernkraftwerksblöcke.

Damit beginnt ein weltweites Wettrennen um verfügbare Stromkapazitäten. Hyperscaler sichern sich bereits über langfristige Verträge gewaltige Energiemengen, während Stromnetze und Erzeugungskapazitäten mit dem Ausbau kaum Schritt halten können. Zusätzlich verschärfen geopolitische Risiken rund um den Iran-Krieg und die Straße von Hormus die Situation.

Für Energieversorger und ihre Zulieferer könnte damit ein goldenes Zeitalter beginnen. Steigende Nachfrage, langfristige Abnahmeverträge und wachsende Strompreise schaffen ein Umfeld, in dem ausgewählte Unternehmen zum nächsten großen KI-Trade werden könnten.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die besonders stark vom explodierenden Energiehunger der KI profitieren könnten – und bei Anlegern bislang teilweise noch unter dem Radar laufen.

Jetzt den kostenlosen Report sichern – und die nächsten Gewinner des KI-Booms entdecken!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.